News
Eli Lilly then spurred it on further with tirzepatide — a GLP-1RA and gastric inhibitory polypeptide (GIP) agonist. Tirzepatide is sold under the brand names Mounjaro and Zepbound for T2D ...
The future of treating metabolic dysfunction–associated steatohepatitis (MASH) looks brighter than ever, says Naim Alkhouri, MD, as data emerges on newly developed interventions.
2mon
GlobalData on MSNPalatin concludes Phase II trial of combination therapy for obesitya glucagon-like peptide-1 (GLP-1)/gastric inhibitory polypeptide (GIP), to treat obesity. The final output collection and ...
Hosted on MSN6mon
Amgen downgraded at Truist on MariTide prospects for obesityAnalyst Robyn Karnauskas wrote that when phase 2 data on MariTide, a GLP-1 receptor and gastric inhibitory polypeptide receptor comes out, it will likely reflect prior data. And given the current ...
which evaluated the co-administration of melanocortin 4 receptor or MC4R agonist bremelanotide plus glucagon like peptide-1/gastric inhibitory polypeptide or GLP-1/GIP tirzepatide arm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results